Skip to content

Cianna J Piercey

5 papers in the library · 10 citations · publishing 2022-2026

Papers

Sort Most recent Most cited

Kava (Piper methysticum) consumption patterns and conceptualizations: results from an online survey.

Substance Abuse Treatment, Prevention, and Policy May 5, 2026 Katherine G. W. Hill, Cianna J Piercey, Hollis C Karoly et al.

'Kava,' or 'kava kava,' (Piper methysticum) is a psychoactive plant indigenous to the Pacific Islands. Historical consumption is reported to provide anxiolytic and sedating effects. In regions where kava is native, it has been used in religious and cultural practices, as well as for medicinal purposes. The mechanisms by which kavalactones - the best studied psychoactive constituent of kava -...

DOI: 10.1186/s13011-026-00728-3 (opens in new tab) Full text (opens in new tab) Piper methysticum Alcohol Harm-reduction Kava +1

Characteristics of adverse reactions to kratom and implementation of harm reduction strategies in a sample of ethnobotanical tea bar patrons in Colorado.

Harm Reduction Journal March 2, 2026 Cianna J Piercey, Joseph Cameron, Riley Ahern et al.

Kratom is a psychoactive botanical that is increasingly popular in the United States. While potential risks of kratom use have been identified, research on harm reduction strategies and contextual factors contributing to adverse reactions is limited. Given that kratom is federally unregulated at present, and a variety of kratom products are widely available on the commercial market, more data...

DOI: 10.1186/s12954-025-01382-x (opens in new tab) Full text (opens in new tab) Adverse effects Ethnobotanical tea bars Field survey Harm reduction +3

Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.

Psychedelic Medicine December 1, 2024 Cianna J Piercey, Bethany A. Gray, Angelina Sung et al. 5 citations

Approximately 8.5 million Americans over the age of 12 endorsed past year psychedelic use in 2022, with 1.4 million individuals initiating use during this time. Although emerging evidence indicates there may be beneficial aspects of psychedelic use, there is a need to understand how individuals might mitigate potential risks within nonclinical contexts, such as through the use of protective...

DOI: 10.1089/psymed.2023.0052 (opens in new tab) Full text (opens in new tab) Protective behavioral strategies Harm reduction Safety protocols Safe use +4

Simultaneous cannabis and psychedelic use among festival and concert attendees in Colorado: characterizing enhancement and adverse reactions using mixed methods.

Journal of Cannabis Research July 11, 2024 Cianna J Piercey, Eleftherios Hetelekides, Hollis C Karoly 5 citations

Background: Most studies examining the simultaneous use of cannabis with other drugs have focused on cannabis and alcohol, with fewer studies examining simultaneous use of cannabis with other drugs. The United States is currently experiencing an upward trend in psychedelic use and there is an increasing need to characterize cannabis and psychedelic drug interactions to best inform public health...

Protocol for a mobile laboratory study of co-administration of cannabis concentrates with a standard alcohol dose in humans.

PLoS One 2022 Hollis C Karoly, Mark A. Prince, Noah N Emery et al.

Cannabis is commonly used among people who drink alcohol, yet evidence on acute effects of co-use is conflicting. Two important variables that may influence the effects of cannabis and alcohol are cannabinoid content (i.e., the ratio of cannabidiol [CBD] and 9-tetrahydrocannabinol [THC]) as well as the order of use (i.e., cannabis before alcohol vs. alcohol before cannabis). Research is mixed...